The development p38 MAP kinase inhibitors

被引：0

作者：

Hynes, John ^{[1
]}

Wu, H. ^{[1
]}

Dyckman, A. J. ^{[1
]}

Lin, S. ^{[1
]}

Wrobleski, S. T. ^{[1
]}

Gillooly, K. M. ^{[1
]}

McIntyre, K. W. ^{[1
]}

Pitt, S. ^{[1
]}

Shen, D. R. ^{[1
]}

Shuster, D. J. ^{[1
]}

Xia, X. ^{[1
]}

Zhang, R. ^{[1
]}

机构：

[1] Bristol Myers Squibb, Dept Discovery Chem, Princeton, NJ USA

来源：

INFLAMMATION RESEARCH | 2007年 / 56卷

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：S474 / S474

页数：1

共 50 条

[41] Design, synthesis, and SAR of a novel series of p38α MAP kinase inhibitors
Martin, Barrie P.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[42] Quantitative structure activity relationship study of p38α MAP kinase inhibitors
Pourbasheer, Eslam
Ahmadpour, Sajjad
Zare-Dorabei, Rohollah
Nekoei, Mehdi
[J]. ARABIAN JOURNAL OF CHEMISTRY, 2017, 10 (01) : 33 - 40
[43] SAR of benzoylpyridines and benzophenones as p38α MAP kinase inhibitors with oral activity
Revesz, L
Blum, E
Di Padova, FE
Buhl, T
Feifel, R
Gram, H
Hiestand, P
Manning, U
Rucklin, G
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (13) : 3601 - 3605
[44] Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster
Kyoi, S
Otani, H
Matsuhisa, S
Akita, Y
Tatsumi, K
Enoki, C
Fujiwara, H
Imamura, H
Kamihata, H
Iwasaka, T
[J]. CARDIOVASCULAR RESEARCH, 2006, 69 (04) : 888 - 898
[45] Synthesis and SAR of p38α MAP kinase inhibitors based on heterobicyclic scaffolds
Dhar, T. G. Murali
Wrobleski, Stephen T.
Lin, Shuqun
Furch, Joseph A.
Nirschl, David S.
Fan, Yi
Todderud, Gordon
Pitt, Sidney
Doweyko, Arthur M.
Sack, John S.
Mathur, Arvind
McKinnon, Murray
Barrish, Joel C.
Dodd, John H.
Schieven, Gary L.
Leftheris, Katerina
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5019 - 5024
[46] Development of aniline amides containing alternative cores as orally active p38 map kinase inhibitors
Leftheris, K
Hynes, J
Dyckman, A
Li, TL
Lin, S
Wrobleski, ST
Wu, H
Zhang, R
Gillooly, KM
Loo, D
McIntyre, KI
Pitt, S
Shen, DR
Shuster, DJ
Doweyko, A
Sack, J
Barrish, JC
Dodd, J
Schieven, GL
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U161 - U161
[47] Role of p38 MAP kinase in the development of acute lung injury
Arcaroli, J
Yum, HK
Kupfner, J
Park, JS
Yang, KY
Abraham, E
[J]. CLINICAL IMMUNOLOGY, 2001, 101 (02) : 211 - 219
[48] Kinetic mechanism for p38 MAP kinase
LoGrasso, PV
Frantz, B
Rolando, AM
OKeefe, SJ
Hermes, JD
ONeill, EA
[J]. BIOCHEMISTRY, 1997, 36 (34) : 10422 - 10427
[49] ERK and p38 MAP kinase are required for rat renal development
Hida, M
Omori, S
Awazu, M
[J]. KIDNEY INTERNATIONAL, 2002, 61 (04) : 1252 - 1262
[50] p38 MAP kinase activity modulates αβ T cell development
Mulroy, T
Sen, J
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (10) : 3056 - 3063

← 1 2 3 4 5 →